Transplantation of Cultured Islets from Two-Layer Preserved Pancreases in Type 1 Diabetes with Anti-CD3 Antibody

American Journal of Transplantation

Volumn 4, Issue 3, 2004, Pages 390-401

  Hering, Bernhard J ^a   Kandaswamy, Raja ^a   Harmon, James V ^a   Ansite, Jeffrey D ^a   Clemmings, Sue M ^a   Sakai, Tetsuya ^a   Paraskevas, Stephen ^a   Eckman, Peter M ^a   Sageshima, Junichiro ^a   Nakanoa, Masahiko ^a   Sawada, Toshiya ^a   Matsumotoa, Ippei ^a   Zhang, Hui J ^a   Sutherland, David E R ^a   Bluestone, Jeffrey A ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; CD4+CD25+ T cells; Diabetes mellitus; HOKT3 1 (Ala Ala); Humanized OKT3; Hypoglycemia; Immunosuppression; Insulin independence; Islet culture; Islet transplants; Perfluorocarbon; Perfluorodecalin; Rapamycin; Single donor

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFECTIVE AGENT; CD4 ANTIGEN; CD8 ANTIGEN; ENOXAPARIN; FC RECEPTOR; HEPARIN; INSULIN; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY CD3; NYSTATIN; OKT 3; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; CELL PROLIFERATION; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG FEVER; FEMALE; HUMAN; HUMAN CELL; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTOPENIA; MALE; MICROALBUMINURIA; MOUTH ULCER; NAUSEA; NEUTROPENIA; PANCREAS; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RASH; T LYMPHOCYTE; TREATMENT OUTCOME;

ADULT; ANTIGENS, CD3; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; MUROMONAB-CD3; PANCREAS; T-LYMPHOCYTE SUBSETS; TISSUE DONORS;

EID: 10744219939     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-6143.2003.00351.x     Document Type: Article

References (51)

1. Nathan D. Long-term complications of diabetes mellitus. N Engl J Med 1993; 328: 1676-1684.
2. The DCCT Research Group. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
3. The DCCT Research Group. Epidemiology of severe hypoglycemia in the diabetic control and complications trial. Am J Med 1991; 90: 450-459.
4. Shapiro AMJ, Lakey JRT, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
5. Shapiro AMJ, Ricordi C, Hering BJ. Edmonton's islet success has indeed been replicated elsewhere. Lancet 2003; 362: 1242.
6. Hering BJ, Matsumoto I, Sawada T, Nakano M, Kandaswamy R, Sutherland DER. Impact of two-layer pancreas preservation on islet isolation and transplantation. Transplantation 2002; 74: 1813-1816.
7. Tanioka Y, Sutherland DE, Kuroda Y et al. Excellence of the two-layer method (University of Wisconsin solution/perfluorochemical) in pancreas preservation before islet isolation. Surgery 1997; 122: 435-441.
8. Hiraoka K, Trexler A, Fujioka B et al. Optimal temperature in pancreas preservation by the two-layer cold storage method before islet isolation. Transplant Proc 2001; 33: 891-892.
9. Hering BJ, Bretzel RG, Hopt UT et al. New protocol toward prevention of early human islet allograft failure. Transplant Proc 1994; 26: 570-571.
10. Hering BJ, Ricordi C, Islet transplantation for patients with type 1 diabetes. Results, research priorities and reasons for optimism. Graft 1999; 2: 12-27.
11. Woodle ES, Xu D, Zivin RA et al. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOK3γ 1 (Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation 1999; 68: 608-616.
12. Chatenoud L, Thervet E, Primo J, Bach JF. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Nat Acad Sci U S A 1994; 91: 123-127.
13. Alegre ML, Peterson LJXD, Sattar HA et al. A non-activating 'humanized' anti CD3 monoclonal antibody retains immunosuppressive properties in vivo. Transplantation 1994; 57: 1537-1543.
14. Herold KC, Hagopian W, Auger JA et al. Anti CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002; 346: 1692-1698.
15. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. Diabetes Care 1995; 18: 517-528.
16. Chatenoud L. Humoral immune response against OKT3. Transplant Proc 1993; 25: 68-73.
17. Verge C, Gianani R, Kawasaki E et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin GAD512bdc/IA-2 autoantibodies. Diabetes 1996; 45: 926-933.
18. Marsh CL, Perkins JD, Sutherland DER, Corry RJ, Sterioff S. Combined hepatic and pancreaticoduodenal procurement for transplantation. Surg Gynecol Obstet 1989; 168: 254-258.
19. Kuroda Y, Kawamura T, Suzuki Y, Fujiwara H, Yamamoto K, Saitoh Y. A new, simple method for cold storage of the pancreas using perfluorochemical [see comments]. Transplantation 1988; 46: 457-460.
20. 2} method of pancreas preservation before transplantation. Transplantation 2000; 70: 774.
21. Lakey JR, Warnock GL, Shapiro AM et al. Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 1999; 8: 285-292.
22. Linetsky E, Bottino R, Lehmann R, Alejandro R, Inverardi L, Ricordi C. Improved human islet isolation using a new enzyme blend, Liberase. Diabetes 1997; 46: 1120-1123.
23. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988 37: 413-420.
24. Lake SP, Basset PD, Larkins A et al. Large-scale putrification of human islets utilizing discontinuous albuming radient on IBM2991 cell separator. Diabetes 1989; 38 (Suppl. 1): 143-145.
25. Fraga DW, Sabek O, Hathaway DK, Gaber AO. A comparison of media supplement methods for the extended culture of human islet tissue. Transplantation 1998; 65: 1060-1066.
26. Rastellini C, Cicalese L, Zeevi A et al. Long-term culture of viable human pancreatic islets in pyruvate-rich medium. Transplant Proc 1995; 27: 3383-3384.
27. Paraskevas S, Wang R, Li J-M, Agapitos D, Maysinger D, Rosenberg L. Insulin-like growth factors promote islet cell survival in vitro through MAP kinase mediated signalling. Transplantation 2000; 69: 4-27.
28. Jahr H, Hussmann B, Eckhard T, Bretzel RG, Successful single donor islet allotransplantation in the streptozotocin diabetes rat model. Cell Transplant 2002; 11: 513-518.
29. Ricordi C, Gray DW, Hering BJ et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990; 27: 185-195.
30. Teuscher AU, Kendall DM, Smets YF, Leone JP, Sutherland DE, Robertson RP. Successful islet autotransplantation in humans. functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 1998; 47: 324-330.
31. [No authors listed]. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
32. Ryan EA, Lakey JR, Rajotte RV et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001; 50: 710-719.
33. Matsumoto S, Kuroda Y. Perfluorocarbon for organ preservation before transplantation. Transplantation 2002; 74: 1804-1809.
34. Fraker C, Alejandro R, Ricordi C. Use of oxygenated perfluorocarbon toward making every pancreas count. Transplantation 2002; 74: 1811-1812.
35. Lakey JR, Tsujimura T, Shapiro AM, Kuroda Y. Preservation of the human pancreas before islet isolation using a two-layer (UW solution-perfluorochemical) cold storage method. Transplantation 2002; 74: 1809-1811.
36. Ricordi C, Fraker C, Szust J et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 2003; 75: 1524-1527.
37. Matsumoto I, Sawada T, Nakano M et al. Significant impact of two-layer (Perfluorochemical/University of Wisconsin Solution [PFC/UW]) method on islet yield and function for short-term preservation of human donor pancreata prior to islet isolation and transplantation. Transplant Proc 2003, submitted.
38. Tsujimura T, Kuroda Y, Kin T et al. Human islet transplantation from pancreases with prolonged cold ischemia using additional preservation by the two-layer (UW solution/perfluorochemical) cold-storage method. Transplantation 2002; 74: 1687-1691.
39. Herbelin A, Chatenoud L, Roux-Lombard P et al. In vivo soluble tumor necrosis factor receptor release in OKT3-treated patients. Transplantation 1995; 10: 1470-1475.
40. Chatenoud L, Ferran C, Legendre C et al. In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids. Transplantation 1990; 49: 697-702.
41. Herold KC, Burton JB, Francois F, Poumian-Ruiz E, Glandt M, Bluestone JA. Activation of human T cells by FcR, nonbinding anti CD3 mAb hOKT3γ 1 (Ala-Ala). J Clin Invest 2003; 111: 409-418.
42. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
43. Shevach EM. CD4+ CD25+ suppressor T cells. more questions than answers. Nat Rev Immunol 2002; 2: 389-400.
44. Kukreja A, Cost G, Marker J et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2002; 109: 131-140.
45. Nicolls MR, Aversa GG, Pearce NW et al. Induction of long-term specific tolerance to allografts in rats by therapy with an anti CID3-like monoclonal antibody. Transplantation 1993; 55: 459-468.
46. Chen J, Huoam C, Plain K, He XY, Hodgkinson SJ, Hall BM. CD4 (+) CD25 (+) T cells as regulators of alloimmune responses. Transplant Proc 2001; 33: 163-164.
47. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH. Identification and functional characterization of human CD4 (+) CD25 (+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001; 193: 1285-1294.
48. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+ CD25 high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245-1253.
49. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641-1646.
50. Chatenoud L. CD3-specific antibody-induced active tolerance from bench to bedside. Nat Rev Immunol 2003; 3: 123-132.
51. Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 2000: 626-632.